Evotec CEO Dr. Werner Lanthaler Steps Down Immediately
Ticker: EVOTF · Form: 6-K · Filed: Jan 3, 2024 · CIK: 1412558
| Field | Detail |
|---|---|
| Company | Evotec Se (EVOTF) |
| Form Type | 6-K |
| Filed Date | Jan 3, 2024 |
| Risk Level | high |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: CEO-transition, leadership-change, corporate-governance
TL;DR
**Evotec's CEO just quit, expect some market jitters.**
AI Summary
Evotec SE announced on January 3, 2024, that its CEO, Dr. Werner Lanthaler, has decided to step down immediately, not serving until the end of his current term. This unexpected leadership change could introduce uncertainty regarding the company's strategic direction and future performance, potentially impacting investor confidence and the stock price for current and prospective shareholders.
Why It Matters
A sudden CEO departure can signal instability or a shift in company strategy, which can make investors nervous about future growth and stock performance.
Risk Assessment
Risk Level: high — The immediate departure of a CEO creates significant leadership uncertainty, which is a high-risk factor for any company.
Analyst Insight
A smart investor would closely monitor Evotec SE's stock for increased volatility and await further announcements regarding new leadership and strategic direction before making significant investment decisions.
Key Players & Entities
- Evotec SE (company) — the registrant filing the 6-K
- Dr. Werner Lanthaler (person) — the outgoing CEO of Evotec SE
- Laetitia Rouxel (person) — Chief Financial Officer who signed the report
- January 3, 2024 (date) — date of the announcement and filing
Forward-Looking Statements
- Evotec SE's stock price (EVO) will experience short-term volatility due to leadership uncertainty. (Evotec SE) — high confidence, target: 2024-01-31
- Evotec SE will announce an interim or new CEO within the next three months. (Evotec SE) — medium confidence, target: 2024-04-03
FAQ
What is the primary announcement made by Evotec SE in this 6-K filing?
Evotec SE announced that its CEO, Dr. Werner Lanthaler, has decided to step down and will not continue to serve until the end of his current term, as stated in the Ad-Hoc announcement on January 3, 2024.
Who signed the 6-K report on behalf of Evotec SE?
The 6-K report was signed by Laetitia Rouxel, the Chief Financial Officer of Evotec SE, on January 3, 2024.
What exhibits were included as part of this Form 6-K?
The Form 6-K included two exhibits: Exhibit 99.1, an Ad-Hoc announcement titled 'Evotec announces CEO transition,' and Exhibit 99.2, an accompanying press release also titled 'Evotec announces CEO transition.'
What is Evotec SE's NASDAQ ticker symbol?
Evotec SE's NASDAQ ticker symbol is EVO, as mentioned in Exhibit 99.1.
When was the Form 6-K filed with the SEC?
The Form 6-K was filed as of January 3, 2024, according to the filing header information.
Filing Stats: 269 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2024-01-03 16:59:00
Filing Documents
- evo_6k.htm (6-K) — 11KB
- evo_ex991.htm (EX-99.1) — 3KB
- evo_ex992.htm (EX-99.2) — 2KB
- evo_ex992img1.jpg (GRAPHIC) — 150KB
- evo_ex992img2.jpg (GRAPHIC) — 189KB
- evo_ex992img3.jpg (GRAPHIC) — 31KB
- 0001654954-24-000152.txt ( ) — 527KB
From the Filing
evo_6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a16 OR 15d16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF JANUARY 2024 COMMISSION FILE NUMBER 001-34041 Evotec SE (Translation of registrant's name into English) Essener Bogen 7 22419 Hamburg Germany Tel: +49 40 560810 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20F or Form 40F: Form 20F Form 40F Indicate by check mark if the registrant is submitting the Form 6K in paper as permitted by Regulation ST Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6K in paper as permitted by Regulation ST Rule 101(b)(7): DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K Explanatory Note On January 03, 2024, Evotec SE issued an Ad-Hoc announcement stating that CEO Dr Werner Lanthaler has informed the company that he has decided to step down as CEO and will not continue to serve until the end of his current term. A copy of the Ad-Hoc announcement is attached as Exhibit 99.1 hereto. A copy of the accompanying press release is attached as Exhibit 99.2 hereto. 2 SIGNATURE Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evotec SE By: /s/ Laetitia Rouxel Name: Laetitia Rouxel Title: Chief Financial Officer Date: 03 rd January 2024 3 EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Evotec announces CEO transition 99.2 Evotec announces CEO transition 4